Mimedx (MDXG) Tax Rate Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,986.00 |
| Dec 31, 2025 | 2,451.00 |
| Sep 30, 2025 | 2,690.00 |
| Jun 30, 2025 | 2,638.00 |
| Mar 31, 2025 | -5,165.00 |
| Dec 31, 2024 | 3,691.00 |
| Sep 30, 2024 | 3,357.00 |
| Jun 30, 2024 | 2,434.00 |
| Mar 31, 2024 | 2,090.00 |
| Dec 31, 2023 | 4,645.00 |
| Sep 30, 2023 | -13,145.00 |
| Jun 30, 2023 | -8.00 |
| Mar 31, 2023 | 4,791.00 |
| Dec 31, 2022 | -5,015.00 |
| Sep 30, 2022 | 319.00 |
| Jun 30, 2022 | -1,445.00 |
| Mar 31, 2022 | -524.00 |
| Dec 31, 2021 | -15,035.00 |
| Sep 30, 2021 | -4,282.00 |
| Jun 30, 2021 | -4,247.00 |
| Mar 31, 2021 | -1,586.00 |
| Dec 31, 2020 | 7,992.00 |
| Sep 30, 2020 | -255.00 |
| Jun 30, 2020 | -426.00 |
| Mar 31, 2020 | 6,665.00 |
| Dec 31, 2019 | -2,048.00 |
| Sep 30, 2019 | -315.00 |
| Jun 30, 2019 | -274.00 |
| Mar 31, 2019 | 78.00 |
| Dec 31, 2018 | -31,487.00 |
| Sep 30, 2018 | 15,564.00 |
| Mar 31, 2018 | -4,740.00 |